$1.76
0.1710.57%
Last update: Jun 17, 11:26 AM
PepGen Inc Stock News
PEPGNASDAQ
Latest PepGen Stock News | NASDAQ:PEPG | Benzinga
Get the latest news on PepGen stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on PepGen performance
Categories: All
Tuesday, June 16, 2026
Thursday, May 21, 2026
Tuesday, May 19, 2026
Wednesday, May 13, 2026
Tuesday, May 12, 2026
Wednesday, April 08, 2026
Wednesday, April 01, 2026
Tuesday, March 31, 2026
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Gold Gains Over 1%; FactSet Research Raises FY2026 Outlook
- PepGen shares are trading lower after the com...PRO
- Wedbush Maintains Outperform on PepGen, Lower...PRO
- Dow Jumps 400 Points; TD Synnex Posts Upbeat Earnings
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Why Is PepGen Stock Sinking Tuesday?
- Why Virgin Galactic Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Monday, March 30, 2026
Monday, March 23, 2026
Thursday, March 05, 2026
- PepGen shares are trading lower after the com...PRO
- Grocery Outlet Posts Downbeat Q4 Earnings, Joins SES AI, PepGen And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Why Veeva Systems Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
- FDA Places Partial Hold On PepGen's Myotonic Dystrophy Drug Trial
Wednesday, March 04, 2026
Wednesday, February 25, 2026
Wednesday, February 18, 2026
Friday, February 06, 2026
Thursday, December 11, 2025
Monday, December 08, 2025
Thursday, November 13, 2025
Wednesday, November 12, 2025
Tuesday, October 28, 2025
Monday, October 27, 2025
Monday, October 13, 2025
Tuesday, September 30, 2025
Friday, September 26, 2025
Thursday, September 25, 2025
- Stifel Maintains Buy on PepGen, Raises Price ...PRO
- S&P 500 Falls 1%; Accenture Posts Upbeat Earnings
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Nasdaq Down Over 1%; US Initial Jobless Claims Fall
- PepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock Doubles
- Wedbush Maintains Outperform on PepGen, Raise...PRO
